Copyright
©2014 Baishideng Publishing Group Co.
World J Diabetes. Apr 15, 2014; 5(2): 115-127
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.115
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.115
Figure 5 Distribution of baseline (aspirin-free) and post-aspirin urinary 11-dehydro-thromboxane B2 levels (pg/mg) measured in healthy individuals (right) and diabetes patients (left).
14.8% of diabetes patients were classified as aspirin (ASA) poor responders compared to 8.4% of healthy controls (post-ASA 11-dehydro-thromboxane B2 over the cutoff 1500 pg/mg).
- Citation: Lopez LR, Guyer KE, Torre IGDL, Pitts KR, Matsuura E, Ames PR. Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease. World J Diabetes 2014; 5(2): 115-127
- URL: https://www.wjgnet.com/1948-9358/full/v5/i2/115.htm
- DOI: https://dx.doi.org/10.4239/wjd.v5.i2.115